论文部分内容阅读
Background: Renal-cell carcinoma (RCC) is resistant to almost all chemotherapeutics and radiation therapy.Wnt/β-catenin signaling plays an important role in RCC tumorigenesis,a drug targeting the Wnt signaling is likely to have therapeutic benefit.15-oxospiramilactone is a new Wnt molecule inhibiter.